CELLECTIS - ADR (CLLS) Institutional Shareholders
CELLECTIS - ADR (CLLS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $30.62M in CLLS holdings during the latest filing period.
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc is currently the largest disclosed institutional shareholder of CLLS tracked by InsiderSet, reporting ownership valued at approximately $10.08M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $4.86M, representing an estimated loss of -51.74% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 99% of the total disclosed CLLS value among the investors covered in this analysis. Major shareholders include Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc, B Group, Inc., Long Focus Capital Management, Llc, and several other long-term asset managers with concentrated positions in CELLECTIS - ADR (CLLS).
This page ranks the largest institutional CLLS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
27
Total Reported Value
$30.62M
Largest Holder
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc
Largest Position
$10.08M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
42
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc | 0.00% | 3,178,620 | $10,076,226 | $4,863,289 | -$5,212,937 | -51.74% | |
| B Group, Inc. | 5.59% | 3,281,501 | $9,844,503 | $5,020,697 | -$4,823,806 | -49.00% | |
| Long Focus Capital Management, Llc | 0.34% | 2,741,853 | $8,225,559 | $4,195,035 | -$4,030,524 | -49.00% | |
| Nomura Asset Management International Inc. | 0.00% | 226,875 | $681,000 | $347,119 | -$333,881 | -49.03% | |
| Blackrock, Inc. | 0.00% | 225,444 | $676,332 | $344,929 | -$331,403 | -49.00% | |
| Morgan Stanley | 0.00% | 85,455 | $256,365 | $130,746 | -$125,619 | -49.00% | |
| Lpl Financial Llc | 0.00% | 84,415 | $253,245 | $129,155 | -$124,090 | -49.00% | |
| Susquehanna International Group, Llp | 0.00% | 50,453 | $151,359 | $77,193 | -$74,166 | -49.00% | |
| Bnp Paribas Financial Markets | 0.00% | 40,100 | $120,300 | $61,353 | -$58,947 | -49.00% | |
| Ubs Group Ag | 0.00% | 33,926 | $101,778 | $51,907 | -$49,871 | -49.00% | |
| Delaney Dennis R | 0.02% | 24,000 | $72,000 | $36,720 | -$35,280 | -49.00% | |
| Rhumbline Advisers | 0.00% | 14,328 | $42,984 | $21,922 | -$21,062 | -49.00% | |
| Xtx Topco Ltd | 0.00% | 12,282 | $36,846 | $18,791 | -$18,055 | -49.00% | |
| First Affirmative Financial Network | 0.01% | 10,149 | $28,925 | $15,528 | -$13,397 | -46.32% | |
| Harbour Investments, Inc. | 0.00% | 4,500 | $13,500 | $6,885 | -$6,615 | -49.00% | |
| National Bank Of Canada | 0.00% | 3,600 | $10,800 | $5,508 | -$5,292 | -49.00% | |
| Wells Fargo & Company/Mn | 0.00% | 3,150 | $9,450 | $4,820 | -$4,631 | -49.00% | |
| Royal Bank Of Canada | 0.00% | 1,558 | $5,000 | $2,384 | -$2,616 | -52.33% | |
| Atlantic Union Bankshares Corp | 0.00% | 1,500 | $4,500 | $2,295 | -$2,205 | -49.00% | |
| Allworth Financial Lp | 0.00% | 500 | $1,500 | $765 | -$735 | -49.00% | |
| Pom Investment Strategies, Llc | 0.00% | 495 | $1,485 | $757 | -$728 | -49.00% | |
| Gamma Investing Llc | 0.00% | 463 | $1,389 | $708 | -$681 | -49.00% | |
| Osaic Holdings, Inc. | 0.00% | 100 | $300 | $153 | -$147 | -49.00% | |
| Larson Financial Group Llc | 0.00% | 75 | $225 | $115 | -$110 | -49.00% | |
| Caitong International Asset Management Co., Ltd | 0.00% | 49 | $147 | $75 | -$72 | -49.00% | |
| Jones Financial Companies Lllp | 0.00% | 50 | $142 | $77 | -$66 | -46.13% | |
| Inspire Investing, Llc | 0.00% | 6 | $18 | $9 | -$9 | -49.00% |
Frequently asked questions about CLLS
Who owns the most CLLS stock?
The largest holders of CLLS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for CELLECTIS - ADR (CLLS).
Is CLLS widely held by superinvestors?
Many widely followed stocks like CLLS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CLLS is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.